The genome editing is expected to be valued at US$ 6.2 billion in 2024. Genome editing is projected to grow at a moderate CAGR of 15.7% from 2024 to 2034. The global genome editing market size is predicted to reach US$ 26.5 billion by 2034.
| Attributes | Key Insights |
|---|---|
| Estimated Market Size in 2024 | US$ 6.2 billion |
| Projected Market Value in 2034 | US$ 26.5 billion |
| Value-based CAGR from 2024 to 2034 | 15.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Genome editing accounted for 18.4% CAGR from 2019 to 2023. Genome editing tools continue to advance in their delivery methods. The efficiency and safety of CRISPR editing were being improved by developing new and improved methods of delivering CRISPR components to target cells.
Personalized and targeted gene therapies for cancer are being explored using genome editing. Cancer cells can be targeted and destroyed by immune cells that have been enhanced to target and destroy them by scientists.
A growing emphasis was placed on public awareness and engagement as genome editing technologies gained traction. In addition to exploring the potential benefits and risks of gene editing, there was also a conversation about the ethical implications. A 15.7% CAGR is forecast between 2024 and 2034.
| Historical CAGR from 2019 to 2023 | 18.4% |
|---|---|
| Forecast CAGR from 2024 to 2034 | 15.7% |
Principal Consultant
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
According to the table provided, South Korea and the United Kingdom have the highest gene editing market revenue. As genome editing technology develops, it will significantly impact the future of the market.
Biological parts, devices, and systems can be designed and constructed through synthetic biology. This technology enables the development of new gene-editing methods and tools, expanding the application possibilities of genome editing.
Gene-editing tools can be delivered to target cells with increased precision using nanotechnology. Genome editing can be more efficient and safer by engineered nanoparticles that carry gene-editing components.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 15.9% |
| China | 16.2% |
| Japan | 16.5% |
| South Korea | 17.8% |
| The United Kingdom | 17.1% |
A high demand for genome editing is expected in the United States. A CAGR of 15.9% is forecast for the market during the period. Regulatory scrutiny of genome editing technologies, particularly those that may be applied to human therapeutic applications, has been conducted by agencies such as the Food and Drug Administration (FDA).
The United States witnessed several ongoing ethical debates, especially regarding the use of germline editing, as well as the use of genome editing in humans. Technology advancements and an expanding hospital infrastructure are expected to increase the demand for genome editing in the United States.
China is predicted to have a growing market for genome editing. The growth rate is expected to be 16.2% between 2024 and 2034. The market is expected to reach US$ 4.2 billion by 2034. The government has contributed significantly to genome editing research and biotech development, fostering innovation and accelerating technology development.
China has dominated research and development in genome editing. Regulations have been implemented to regulate gene editing in humans, though concerns remain about regulating private ventures. A call for stricter regulations and international cooperation has arisen in response to ethical concerns regarding gene editing.
Japan is expected to lead the market for genome editing market. A 16.5% CAGR is predicted for the market during the forecast period. By 2034, the market is expected to generate US$ 2.8 billion in revenues. Biotechnology is one of Japan's most advanced fields. Several technological advances have contributed to the growth of genome editing in Japan.
Age-related diseases are among the top medical innovations in Japan, which is one of the world's most rapidly aging populations. A growing interest in genome editing in Japan is driven by its potential to develop personalized treatments for diseases caused by aging.
Research and development in genome editing has been a major focus of South Korea, contributing significantly to the field. A market growth of US$ 1.6 billion is anticipated by 2034. South Korea has conducted extensive research into genome editing. Using CRISPR-Cas9 gene scissors and other gene-editing technologies, the country has been actively involved in developing and applying gene-editing technologies.
Several biotech companies in South Korea specialize in genome editing technologies. The products or services provided by some companies include new therapies, gene editing, and agricultural applications. The biotechnology industry in South Korea is highly competitive, and it places great importance on research and development. South Korea invests heavily in cutting-edge technologies that promote growth and innovation as part of its initiatives to maintain its competitiveness globally.
Many renowned universities and research institutions throughout the United Kingdom are actively involved in genome editing research. Research from these institutions is often relevant to medicine and agriculture and contributes to the advancement of the field.
The regulatory environment heavily influences genome editing market dynamics in the United Kingdom. A policy to balance ethical and safety considerations with innovation is being developed in the United Kingdom with respect to genome editing regulations. The United Kingdom is actively researching genetic disorders and clinical trials using genome editing techniques.
A CAGR of 17.1% is projected for the United Kingdom between 2024 and 2034. Government initiatives, private investors, and international collaborations have all invested in and funded the genome editing industry in the United Kingdom.
This section illustrates the market's leading segment. Based on the technology, the meganucleases segment is expected to expand at a CAGR of 15.6% by 2034. Based on the delivery, the ex-vivo segment is expected to expand at a CAGR of 15.3% by 2034.
| Category | CAGR from 2024 to 2034 |
|---|---|
| Meganucleases | 15.6% |
| Ex-vivo | 15.3% |
A meganuclease's ability to recognize and cut specific DNA sequences is highly precise. By 2034, the meganucleas sector is forecasted to record a CAGR of 15.6%. As a result of their specificity, they can be used for targeted genome editing with minimal off-target effects.
Genome editing and repair can be achieved with meganuclease by inducing homologous recombination. Inactivation of specific genes can be achieved using meganuclease’s that cut and target DNA sequences. For example, CCR5, an important HIV receptor, has been targeted by meganuclease in clinical trials.
Ex CRISPR-Cas9, zinc finger nucleases (ZFNs), or transcription activator-like effector nucleases (TALENs) are among the tools that can be introduced into cells for vivo genome editing. Infecting cells with viruses, electroporation, and lipids can all be accomplished this way, with a variety of techniques available for each.
The ex-vivo market is predicted to expand at a CAGR of 15.3% through 2034. In addition to treating genetic disorders and cancer, ex vivo genome editing is also effective against certain viral infections. Mutations in DNA may be corrected, immune response enhanced, or therapeutic genes may be introduced by altering the genetic material of cells.
The manufacturers of genome editing tools are seeking strategic partnerships and collaborations with other companies to expand their research capabilities. Research and development activities by several market players are leading to innovations in genetic testing.
Key Market Developments
| Attributes | Details |
|---|---|
| Estimated Market Size in 2024 | US$ 6.2 billion |
| Projected Market Valuation in 2034 | US$ 26.5 billion |
| Value-based CAGR 2024 to 2034 | 15.7% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in US$ billion |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
As of 2024, the genome editing market is expected to be valued at US$ 6.2 billion.
By 2034, the market value of genome editing is expected to reach US$ 26.5 billion.
From 2024 to 2034, genome editing is expected to flourish at a CAGR of 15.7%
The meganucleases segment is expected to increase at 15.6% CAGR by 2034.
South Korea is expected to hold the largest market, with a CAGR of 17.8%.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Technology 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2024 to 2034 5.3.1. Meganucleases 5.3.2. (CRISPR)/Cas9 5.3.3. TALENs/MegaTALs 5.3.4. ZFN 5.3.5. Others 5.4. Y-o-Y Growth Trend Analysis By Technology, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Technology, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Delivery 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Delivery, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Delivery, 2024 to 2034 6.3.1. Ex-vivo 6.3.2. In-vivo 6.4. Y-o-Y Growth Trend Analysis By Delivery, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Delivery, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Mode 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Mode, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mode, 2024 to 2034 7.3.1. Contract 7.3.2. In-house 7.4. Y-o-Y Growth Trend Analysis By Mode, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Mode, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End-use 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2024 to 2034 8.3.1. Biotechnology & Pharmaceutical Companies 8.3.2. Academic & Government Research Institutes 8.3.3. Contract Research Organizations 8.4. Y-o-Y Growth Trend Analysis By End-use, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By End-use, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 9.1. Introduction / Key Findings 9.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023 9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034 9.3.1. Genetic Engineering 9.3.1.1. Cell Line Engineering 9.3.1.2. Animal Genetic Engineering 9.3.1.3. Plant Genetic Engineering 9.3.1.4. Others 9.3.2. Clinical Applications 9.3.2.1. Diagnostics 9.3.2.2. Therapy Development 9.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 9.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 10.1. Introduction 10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 10.3.1. North America 10.3.2. Latin America 10.3.3. Western Europe 10.3.4. Eastern Europe 10.3.5. South Asia and Pacific 10.3.6. East Asia 10.3.7. Middle East and Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. USA 11.2.1.2. Canada 11.2.2. By Technology 11.2.3. By Delivery 11.2.4. By Mode 11.2.5. By End-use 11.2.6. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Technology 11.3.3. By Delivery 11.3.4. By Mode 11.3.5. By End-use 11.3.6. By Application 11.4. Key Takeaways 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Brazil 12.2.1.2. Mexico 12.2.1.3. Rest of Latin America 12.2.2. By Technology 12.2.3. By Delivery 12.2.4. By Mode 12.2.5. By End-use 12.2.6. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Technology 12.3.3. By Delivery 12.3.4. By Mode 12.3.5. By End-use 12.3.6. By Application 12.4. Key Takeaways 13. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Germany 13.2.1.2. UK 13.2.1.3. France 13.2.1.4. Spain 13.2.1.5. Italy 13.2.1.6. Rest of Western Europe 13.2.2. By Technology 13.2.3. By Delivery 13.2.4. By Mode 13.2.5. By End-use 13.2.6. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Technology 13.3.3. By Delivery 13.3.4. By Mode 13.3.5. By End-use 13.3.6. By Application 13.4. Key Takeaways 14. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. Poland 14.2.1.2. Russia 14.2.1.3. Czech Republic 14.2.1.4. Romania 14.2.1.5. Rest of Eastern Europe 14.2.2. By Technology 14.2.3. By Delivery 14.2.4. By Mode 14.2.5. By End-use 14.2.6. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Technology 14.3.3. By Delivery 14.3.4. By Mode 14.3.5. By End-use 14.3.6. By Application 14.4. Key Takeaways 15. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. India 15.2.1.2. Bangladesh 15.2.1.3. Australia 15.2.1.4. New Zealand 15.2.1.5. Rest of South Asia and Pacific 15.2.2. By Technology 15.2.3. By Delivery 15.2.4. By Mode 15.2.5. By End-use 15.2.6. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Technology 15.3.3. By Delivery 15.3.4. By Mode 15.3.5. By End-use 15.3.6. By Application 15.4. Key Takeaways 16. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. China 16.2.1.2. Japan 16.2.1.3. South Korea 16.2.2. By Technology 16.2.3. By Delivery 16.2.4. By Mode 16.2.5. By End-use 16.2.6. By Application 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Technology 16.3.3. By Delivery 16.3.4. By Mode 16.3.5. By End-use 16.3.6. By Application 16.4. Key Takeaways 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 17.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 17.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 17.2.1. By Country 17.2.1.1. GCC Countries 17.2.1.2. South Africa 17.2.1.3. Israel 17.2.1.4. Rest of MEA 17.2.2. By Technology 17.2.3. By Delivery 17.2.4. By Mode 17.2.5. By End-use 17.2.6. By Application 17.3. Market Attractiveness Analysis 17.3.1. By Country 17.3.2. By Technology 17.3.3. By Delivery 17.3.4. By Mode 17.3.5. By End-use 17.3.6. By Application 17.4. Key Takeaways 18. Key Countries Market Analysis 18.1. USA 18.1.1. Pricing Analysis 18.1.2. Market Share Analysis, 2023 18.1.2.1. By Technology 18.1.2.2. By Delivery 18.1.2.3. By Mode 18.1.2.4. By End-use 18.1.2.5. By Application 18.2. Canada 18.2.1. Pricing Analysis 18.2.2. Market Share Analysis, 2023 18.2.2.1. By Technology 18.2.2.2. By Delivery 18.2.2.3. By Mode 18.2.2.4. By End-use 18.2.2.5. By Application 18.3. Brazil 18.3.1. Pricing Analysis 18.3.2. Market Share Analysis, 2023 18.3.2.1. By Technology 18.3.2.2. By Delivery 18.3.2.3. By Mode 18.3.2.4. By End-use 18.3.2.5. By Application 18.4. Mexico 18.4.1. Pricing Analysis 18.4.2. Market Share Analysis, 2023 18.4.2.1. By Technology 18.4.2.2. By Delivery 18.4.2.3. By Mode 18.4.2.4. By End-use 18.4.2.5. By Application 18.5. Germany 18.5.1. Pricing Analysis 18.5.2. Market Share Analysis, 2023 18.5.2.1. By Technology 18.5.2.2. By Delivery 18.5.2.3. By Mode 18.5.2.4. By End-use 18.5.2.5. By Application 18.6. UK 18.6.1. Pricing Analysis 18.6.2. Market Share Analysis, 2023 18.6.2.1. By Technology 18.6.2.2. By Delivery 18.6.2.3. By Mode 18.6.2.4. By End-use 18.6.2.5. By Application 18.7. France 18.7.1. Pricing Analysis 18.7.2. Market Share Analysis, 2023 18.7.2.1. By Technology 18.7.2.2. By Delivery 18.7.2.3. By Mode 18.7.2.4. By End-use 18.7.2.5. By Application 18.8. Spain 18.8.1. Pricing Analysis 18.8.2. Market Share Analysis, 2023 18.8.2.1. By Technology 18.8.2.2. By Delivery 18.8.2.3. By Mode 18.8.2.4. By End-use 18.8.2.5. By Application 18.9. Italy 18.9.1. Pricing Analysis 18.9.2. Market Share Analysis, 2023 18.9.2.1. By Technology 18.9.2.2. By Delivery 18.9.2.3. By Mode 18.9.2.4. By End-use 18.9.2.5. By Application 18.10. Poland 18.10.1. Pricing Analysis 18.10.2. Market Share Analysis, 2023 18.10.2.1. By Technology 18.10.2.2. By Delivery 18.10.2.3. By Mode 18.10.2.4. By End-use 18.10.2.5. By Application 18.11. Russia 18.11.1. Pricing Analysis 18.11.2. Market Share Analysis, 2023 18.11.2.1. By Technology 18.11.2.2. By Delivery 18.11.2.3. By Mode 18.11.2.4. By End-use 18.11.2.5. By Application 18.12. Czech Republic 18.12.1. Pricing Analysis 18.12.2. Market Share Analysis, 2023 18.12.2.1. By Technology 18.12.2.2. By Delivery 18.12.2.3. By Mode 18.12.2.4. By End-use 18.12.2.5. By Application 18.13. Romania 18.13.1. Pricing Analysis 18.13.2. Market Share Analysis, 2023 18.13.2.1. By Technology 18.13.2.2. By Delivery 18.13.2.3. By Mode 18.13.2.4. By End-use 18.13.2.5. By Application 18.14. India 18.14.1. Pricing Analysis 18.14.2. Market Share Analysis, 2023 18.14.2.1. By Technology 18.14.2.2. By Delivery 18.14.2.3. By Mode 18.14.2.4. By End-use 18.14.2.5. By Application 18.15. Bangladesh 18.15.1. Pricing Analysis 18.15.2. Market Share Analysis, 2023 18.15.2.1. By Technology 18.15.2.2. By Delivery 18.15.2.3. By Mode 18.15.2.4. By End-use 18.15.2.5. By Application 18.16. Australia 18.16.1. Pricing Analysis 18.16.2. Market Share Analysis, 2023 18.16.2.1. By Technology 18.16.2.2. By Delivery 18.16.2.3. By Mode 18.16.2.4. By End-use 18.16.2.5. By Application 18.17. New Zealand 18.17.1. Pricing Analysis 18.17.2. Market Share Analysis, 2023 18.17.2.1. By Technology 18.17.2.2. By Delivery 18.17.2.3. By Mode 18.17.2.4. By End-use 18.17.2.5. By Application 18.18. China 18.18.1. Pricing Analysis 18.18.2. Market Share Analysis, 2023 18.18.2.1. By Technology 18.18.2.2. By Delivery 18.18.2.3. By Mode 18.18.2.4. By End-use 18.18.2.5. By Application 18.19. Japan 18.19.1. Pricing Analysis 18.19.2. Market Share Analysis, 2023 18.19.2.1. By Technology 18.19.2.2. By Delivery 18.19.2.3. By Mode 18.19.2.4. By End-use 18.19.2.5. By Application 18.20. South Korea 18.20.1. Pricing Analysis 18.20.2. Market Share Analysis, 2023 18.20.2.1. By Technology 18.20.2.2. By Delivery 18.20.2.3. By Mode 18.20.2.4. By End-use 18.20.2.5. By Application 18.21. GCC Countries 18.21.1. Pricing Analysis 18.21.2. Market Share Analysis, 2023 18.21.2.1. By Technology 18.21.2.2. By Delivery 18.21.2.3. By Mode 18.21.2.4. By End-use 18.21.2.5. By Application 18.22. South Africa 18.22.1. Pricing Analysis 18.22.2. Market Share Analysis, 2023 18.22.2.1. By Technology 18.22.2.2. By Delivery 18.22.2.3. By Mode 18.22.2.4. By End-use 18.22.2.5. By Application 18.23. Israel 18.23.1. Pricing Analysis 18.23.2. Market Share Analysis, 2023 18.23.2.1. By Technology 18.23.2.2. By Delivery 18.23.2.3. By Mode 18.23.2.4. By End-use 18.23.2.5. By Application 19. Market Structure Analysis 19.1. Competition Dashboard 19.2. Competition Benchmarking 19.3. Market Share Analysis of Top Players 19.3.1. By Regional 19.3.2. By Technology 19.3.3. By Delivery 19.3.4. By Mode 19.3.5. By End-use 19.3.6. By Application 20. Competition Analysis 20.1. Competition Deep Dive 20.1.1. Merck KGaA 20.1.1.1. Overview 20.1.1.2. Product Portfolio 20.1.1.3. Profitability by Market Segments 20.1.1.4. Sales Footprint 20.1.1.5. Strategy Overview 20.1.1.5.1. Marketing Strategy 20.1.2. Cibus, Recombinetics, Inc. 20.1.2.1. Overview 20.1.2.2. Product Portfolio 20.1.2.3. Profitability by Market Segments 20.1.2.4. Sales Footprint 20.1.2.5. Strategy Overview 20.1.2.5.1. Marketing Strategy 20.1.3. Sangamo 20.1.3.1. Overview 20.1.3.2. Product Portfolio 20.1.3.3. Profitability by Market Segments 20.1.3.4. Sales Footprint 20.1.3.5. Strategy Overview 20.1.3.5.1. Marketing Strategy 20.1.4. Editas Medicine 20.1.4.1. Overview 20.1.4.2. Product Portfolio 20.1.4.3. Profitability by Market Segments 20.1.4.4. Sales Footprint 20.1.4.5. Strategy Overview 20.1.4.5.1. Marketing Strategy 20.1.5. Precision Biosciences 20.1.5.1. Overview 20.1.5.2. Product Portfolio 20.1.5.3. Profitability by Market Segments 20.1.5.4. Sales Footprint 20.1.5.5. Strategy Overview 20.1.5.5.1. Marketing Strategy 20.1.6. CRISPR Therapeutics 20.1.6.1. Overview 20.1.6.2. Product Portfolio 20.1.6.3. Profitability by Market Segments 20.1.6.4. Sales Footprint 20.1.6.5. Strategy Overview 20.1.6.5.1. Marketing Strategy 20.1.7. Intellia Therapeutics, Inc. 20.1.7.1. Overview 20.1.7.2. Product Portfolio 20.1.7.3. Profitability by Market Segments 20.1.7.4. Sales Footprint 20.1.7.5. Strategy Overview 20.1.7.5.1. Marketing Strategy 20.1.8. Caribou Biosciences, Inc. 20.1.8.1. Overview 20.1.8.2. Product Portfolio 20.1.8.3. Profitability by Market Segments 20.1.8.4. Sales Footprint 20.1.8.5. Strategy Overview 20.1.8.5.1. Marketing Strategy 20.1.9. Cellectis S.A. 20.1.9.1. Overview 20.1.9.2. Product Portfolio 20.1.9.3. Profitability by Market Segments 20.1.9.4. Sales Footprint 20.1.9.5. Strategy Overview 20.1.9.5.1. Marketing Strategy 20.1.10. AstraZeneca 20.1.10.1. Overview 20.1.10.2. Product Portfolio 20.1.10.3. Profitability by Market Segments 20.1.10.4. Sales Footprint 20.1.10.5. Strategy Overview 20.1.10.5.1. Marketing Strategy 20.1.11. Takara Bio USA 20.1.11.1. Overview 20.1.11.2. Product Portfolio 20.1.11.3. Profitability by Market Segments 20.1.11.4. Sales Footprint 20.1.11.5. Strategy Overview 20.1.11.5.1. Marketing Strategy 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Genome Editing Market
